Sigal Kaplan
Overview
Explore the profile of Sigal Kaplan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colas S, Nishikawa T, Dresco I, Kaplan S, Marinier K, Lachacinski A, et al.
Pharmacoepidemiol Drug Saf
. 2024 Nov;
33(11):e70046.
PMID: 39532540
Purpose: To assess the impact of the 2018 European additional risk minimisation measures (aRMMs) regarding the use of valproate in women of childbearing potential (WCBP) and during pregnancy. Methods: A...
2.
Gini R, Pajouheshnia R, Gardarsdottir H, Bennett D, Li L, Gulea C, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(5):e5787.
PMID: 38724471
Purpose: Real-world evidence (RWE) is increasingly used for medical regulatory decisions, yet concerns persist regarding its reproducibility and hence validity. This study addresses reproducibility challenges associated with diversity across real-world...
3.
Kaplan S, Dragut C, Ghimpeteanu A
Curr Med Res Opin
. 2024 Apr;
40(5):821-825.
PMID: 38577712
Objectives: This study aimed to examine pregnancy and fetal outcomes following paternal exposure to glatiramer acetate (GA). Methods: Pregnancy reports of paternal GA-exposure at time of conception from 2001 to...
4.
Gitelman V, Kaplan S, Hakkert S
Accid Anal Prev
. 2023 Nov;
195:107399.
PMID: 38011823
Safety policies typically follow Lasswell's linear decision cycle paradigm: diagnostics, prescription, application, monitoring, and appraisal. Contemporary policy research highlights the existence of complexities in policy-making, which trigger policy lock-ins. We...
5.
Kaplan S, Xie H, Wang J
Parkinsonism Relat Disord
. 2023 Nov;
117:105920.
PMID: 37951144
Introduction: Published literature on the prevalence and incidence of multiple system atrophy (MSA) in the US are scarce or based on relatively older studies. The objective of this study was...
6.
Wharton G, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, et al.
Pharmacoepidemiol Drug Saf
. 2023 Sep;
33(1):e5695.
PMID: 37690792
Purpose: Given limited information available on real-world data (RWD) sources with pediatric populations, this study describes features of globally available RWD sources for pediatric pharmacoepidemiologic research. Methods: An online questionnaire...
7.
Kaplan S, Zeygarnik M, Stern T, Hellwig K
Eur J Neurol
. 2023 Aug;
30(12):3890-3895.
PMID: 37565380
Background And Purpose: Data on disease-modifying therapy (DMT) exposure throughout pregnancy in patients with multiple sclerosis are scarce. In this analysis, we assessed pregnancy and fetal outcomes following maternal glatiramer...
8.
Segal J, Varadhan R, Groenwold R, Li X, Nomura K, Kaplan S, et al.
Ann Intern Med
. 2023 Mar;
176(4):536-544.
PMID: 36940440
Increasing availability of real-world data (RWD) generated from patient care enables the generation of evidence to inform clinical decisions for subpopulations of patients and perhaps even individuals. There is growing...
9.
Simsek M, Schepers F, Kaplan S, van Asseldonk D, van Boeckel P, Boekema P, et al.
J Crohns Colitis
. 2023 Jan;
17(6):933-942.
PMID: 36702552
Background And Aims: Thioguanine is a well-tolerated and effective therapy for inflammatory bowel disease [IBD] patients. Prospective effectiveness data are needed to substantiate the role of thioguanine as a maintenance...
10.
Tchetchik A, Kaplan S, Blass V
Resour Conserv Recycl
. 2022 Dec;
167:105370.
PMID: 36570977
The COVID-19 pandemic has created sudden, rapid, and unprecedented change in almost every possible aspect of the general population's behavior. Despite its devastating consequences, the COVID-19 pandemic can alter individual...